ACCRUED EXPENSES (Tables)

3 Months Ended

Mar. 31, 2021

Payables and Accruals [Abstract]

SCHEDULE OF ACCRUED EXPENSES

Accrued expenses consisted of the following:

	March 31, 2021		December 31, 2020
Accrued clinical operations and trials costs	$	11,956,892	$	14,132,842
Accrued product development costs		764,211		2,189,047
Accrued compensation		3,746,283		4,222,594
Accrued other		1,275,088		1,460,949
Total	$	17,742,474	$	22,005,432